Pulmonary embolism special scenario pregnancy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 24: | Line 24: | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Pulmonology]] | [[Category:Pulmonology]] | ||
[[Category:Obstetrics]] | |||
[[Category:Oncology]] | |||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] |
Revision as of 03:02, 8 October 2012
Pulmonary Embolism Microchapters |
Diagnosis |
---|
Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores |
Treatment |
Follow-Up |
Special Scenario |
Trials |
Case Studies |
Pulmonary embolism special scenario pregnancy On the Web |
Directions to Hospitals Treating Pulmonary embolism special scenario pregnancy |
Risk calculators and risk factors for Pulmonary embolism special scenario pregnancy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Special Scenario
Pregnancy
- LMWH is the preferred treatment. (Grade 1C)
- Warfarin is contraindicated.
- Embryopathy is at increased risk at 6 - 12 weeks. (Grade 2C)
- Continue anticoagulation for 6 weeks or more postpartum. (Grade 1C)
- Heparin and warfarin are safe for nursing infants.
Cancer
- Recurrence rate of pulmonary embolism is 30% at one year.
- For treatment LMWH is recommended for initial 3 - 6 months.(Grade 1A)
- Later warfarin can be used after 3-6 months.
- Anticoagulation should be continued